FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

GlobeNewsWire • Jun 30, 2026

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical AUSTIN, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans Healthcare System”). Currently, nearly 500,000 Veterans are receiving prostate cancer treatment or care within the Veterans Healthcare System.

GlobeNewsWire • Jun 16, 2026